Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous TCR-Transduced T-Cells for Metastatic Cancer
NCT03412877Phase 2Recruiting
- Sponsor
- National Cancer Institute
- Start
- Sep 2018
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 2 trial of TCR-transduced peripheral blood lymphocytes in solid tumor, gastrointestinal cancer, genitourinary cancer, breast cancer, ovarian cancer, sponsored by National Cancer Institute. Started Sep 2018; status: recruiting.
02
Drugs
TCR-transduced peripheral blood lymphocytes
03
Conditions
solid tumorgastrointestinal cancergenitourinary cancerbreast cancerovarian cancer
Beyond the preview
Go deeper on NCT03412877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03412877.